Utilization of the Seraph® 100 Affinity Blood Filter in a Pediatric Case of Refractory Streptococcal Septic Shock: A Case Study - Takeaways - MDSpire

Utilization of the Seraph® 100 Affinity Blood Filter in a Pediatric Case of Refractory Streptococcal Septic Shock: A Case Study

  • By

  • Raul Montero-Yeboles

  • Laura Maria Saez-García

  • Esther Ulloa-Santamaria

  • Ana Diaz-Vico

  • Maria Jose Lorenzo-Montero

  • Beatriz Ruiz-Saez

  • April 17, 2026

  • 0 min

Share

  • 1

    Septic shock in pediatrics is a significant cause of morbidity and mortality, especially in refractory cases unresponsive to standard therapy.

  • 2

    The Seraph® 100 Microbind® affinity blood filter was used in a 7-year-old girl with refractory septic shock caused by invasive Streptococcus pyogenes.

  • 3

    Hemoperfusion with the Seraph® 100 filter led to improved hemodynamic stability and metabolic parameters within 24–48 hours post-treatment.

  • 4

    Despite stabilization, the patient suffered severe peripheral ischemia, resulting in bilateral lower-limb amputations but ultimately survived.

  • 5

    The case suggests potential for hemoperfusion as an adjunctive therapy in pediatric septic shock, warranting further prospective studies.

Original Source(s)

Related Content